Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Plos One
|
February 25, 2010
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro
Jack T Nguyen, Justin D Hoopes, Minh H Le, et al.
Journal of Virology
|
March 7, 2008
Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes
Mark N Prichard, Elizabeth Sztul, Shannon L Daily, et al.
Antimicrobial Agents and Chemotherapy
|
September 23, 2009
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides
Mark N Prichard, Debra C Quenelle, Caroll B Hartline, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Synthesis and Antiviral Evaluation of Octadecyloxyethyl Benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a Potent Inhibitor of Transient HPV DNA Amplification
James R Beadle, Nadejda Valiaeva, Guang Yang, et al.
Antiviral Research
|
March 7, 2018
USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses
Karoly Toth, Jacqueline F Spencer, Baoling Ying, et al.
Journal of Virology
|
November 8, 2013
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion
Arnab Basu, Aleksandar Antanasijevic, Minxiu Wang, et al.
Antiviral Research
|
December 13, 2022
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus
Andrea J Parsons, Sabrina I Ophir, Thomas J Gardner, et al.
The Journal of Infectious Diseases
|
December 12, 2012
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza
David W Kimberlin, Edward P Acosta, Mark N Prichard, et al.
Molecular Pharmaceutics
|
December 9, 2022
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin
Elke Lipka, Aaron M Chadderdon, Cheryl C Harteg, et al.
The New England Journal of Medicine
|
March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus disease
David W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Plos One
|
February 25, 2010
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro
Jack T Nguyen, Justin D Hoopes, Minh H Le, et al.
Journal of Virology
|
March 7, 2008
Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes
Mark N Prichard, Elizabeth Sztul, Shannon L Daily, et al.
Antimicrobial Agents and Chemotherapy
|
September 23, 2009
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides
Mark N Prichard, Debra C Quenelle, Caroll B Hartline, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Synthesis and Antiviral Evaluation of Octadecyloxyethyl Benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a Potent Inhibitor of Transient HPV DNA Amplification
James R Beadle, Nadejda Valiaeva, Guang Yang, et al.
Antiviral Research
|
March 7, 2018
USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses
Karoly Toth, Jacqueline F Spencer, Baoling Ying, et al.
Journal of Virology
|
November 8, 2013
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion
Arnab Basu, Aleksandar Antanasijevic, Minxiu Wang, et al.
Antiviral Research
|
December 13, 2022
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus
Andrea J Parsons, Sabrina I Ophir, Thomas J Gardner, et al.
The Journal of Infectious Diseases
|
December 12, 2012
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza
David W Kimberlin, Edward P Acosta, Mark N Prichard, et al.
Molecular Pharmaceutics
|
December 9, 2022
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin
Elke Lipka, Aaron M Chadderdon, Cheryl C Harteg, et al.
The New England Journal of Medicine
|
March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus disease
David W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Page
of 8